---
layout: default
title: Flunitrazepam
description: "Flunitrazepam çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 74
evidence_level: L3
indication_count: 10
---

# Flunitrazepam

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Flunitrazepam (æ°Ÿç¡è¥¿æ³®) - è—¥å¸«è©•ä¼°å ±å‘Š

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Flunitrazepam å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
æ°Ÿç¡è¥¿æ³®æ˜¯ä¸€ç¨®è‹¯äºŒæ°®å¹³é¡å®‰çœ è—¥ï¼ŒTxGNN é æ¸¬å…¶å°å¤±çœ ï¼ˆç–¾ç—…åˆ†é¡ï¼‰æœ‰æ•ˆï¼Œé€™å¯¦éš›ä¸Šèˆ‡å…¶æ ¸å‡†é©æ‡‰ç—‡å®Œå…¨é‡ç–Šï¼›å¦é æ¸¬å°åé ­ç—›å’Œç„¦æ…®æœ‰æ½›åœ¨ç™‚æ•ˆï¼Œéƒ¨åˆ†æœ‰è‡¨åºŠè­‰æ“šæ”¯æŒã€‚
</p>


## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©å­¸å | Flunitrazepam |
| å°ç£å•†å“å | æ°Ÿè€å¦¥çœ  |
| DrugBank ID | DB01544 |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | å¤±çœ ã€å®‰çœ ã€é®éœ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | insomnia (disease)ã€migraine disorderã€migraine with brainstem auraã€anxietyã€ç„¦æ…®ç—‡ã€alcohol withdrawal deliriumã€migraine with or without aura, susceptibility toã€agoraphobiaã€benign paroxysmal torticollis of infancyã€atrophoderma vermiculata |
| æœ€é«˜è­‰æ“šç­‰ç´š | L2 (æœ‰è‡¨åºŠè©¦é©—) |
| å°ç£ä¸Šå¸‚ç‹€æ…‹ | æœ‰æ•ˆè¨±å¯è­‰ï¼ˆç®¡åˆ¶è—¥å“ï¼‰ |




## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. insomnia (disease)</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.89%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>æ°Ÿç¡è¥¿æ³®æ˜¯ä¸€ç¨®å¼·æ•ˆè‹¯äºŒæ°®å¹³é¡è—¥ç‰©ï¼Œå…¶é æ¸¬é©æ‡‰ç—‡èˆ‡å…¶ GABA-A å—é«”èª¿ç¯€æ©Ÿåˆ¶ç›¸é—œï¼š</p>

<ol>
<li><strong>å¤±çœ ï¼ˆç–¾ç—…ï¼‰</strong> (TxGNN Score: 0.999, Rank: 2959)ï¼šé€™å¯¦éš›ä¸Šèˆ‡åŸæ ¸å‡†é©æ‡‰ç—‡ç›¸åŒï¼Œæ˜¯æ¨¡å‹æº–ç¢ºè­˜åˆ¥å·²çŸ¥é©æ‡‰ç—‡çš„ä¾‹è­‰ã€‚</li>

<li><strong>åé ­ç—›</strong> (TxGNN Score: 0.997, Rank: 6338)ï¼šè‹¯äºŒæ°®å¹³é¡è—¥ç‰©å¯èƒ½é€é GABA èƒ½æ©Ÿåˆ¶èª¿ç¯€ç–¼ç—›å‚³å°ï¼Œä¸”åé ­ç—›å¸¸èˆ‡ç¡çœ éšœç¤™å…±ç—…ã€‚</li>

<li><strong>ç„¦æ…®</strong> (TxGNN Score: 0.996, Rank: 7852)ï¼šè‹¯äºŒæ°®å¹³é¡è—¥ç‰©çš„æŠ—ç„¦æ…®ä½œç”¨æ˜¯å…¶æ ¸å¿ƒè—¥ç†ç‰¹æ€§ä¹‹ä¸€ï¼Œæ°Ÿç¡è¥¿æ³®ç¢ºå¯¦å…·æœ‰é¡¯è‘—çš„æŠ—ç„¦æ…®æ•ˆæœã€‚</li>
</ol>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>### å¤±çœ ç›¸é—œè©¦é©—</p>

<table>
<thead>
<tr>
<th>è©¦é©—ç·¨è™Ÿ</th>
<th>æ¨™é¡Œ</th>
<th>éšæ®µ</th>
<th>ç‹€æ…‹</th>
<th>åœ‹å®¶</th>
</tr>
</thead>
<tbody>
<tr>
<td>NCT02648776</td>
<td>è€å¹´äººå®‰çœ è—¥ç‰©é¢¨éšªæ•ˆç›Šè©•ä¼°</td>
<td>N/A</td>
<td>ç‹€æ…‹ä¸æ˜</td>
<td>å°ç£</td>
</tr>
</tbody>
</table>

<p><strong>ç‰¹åˆ¥æ³¨æ„ï¼š</strong> æ­¤è©¦é©—ç”±ä¸­åœ‹é†«è—¥å¤§å­¸é™„è¨­é†«é™¢åŸ·è¡Œï¼Œå°ˆé–€è©•ä¼°å°ç£è€å¹´äººä½¿ç”¨å®‰çœ è—¥ï¼ˆåŒ…å« flunitrazepamï¼‰çš„ç”¨è—¥æ¨¡å¼ã€ç™‚æ•ˆå’Œå®‰å…¨æ€§ã€‚</p>

<h3>ç›¸é—œæ–‡ç»</h3>

<p>é‡å°å¤±çœ é©æ‡‰ç—‡ï¼Œæª¢ç´¢åˆ° 11 ç¯‡ç›¸é—œ PubMed æ–‡ç»ï¼š</p>

<p><strong>é‡é»æ–‡ç»ï¼š</strong></p>

<ol>
<li><strong>Murciano D et al. (1993)</strong> - European Respiratory Journal</li>
</ol>
<ul>
<li>æ¯”è¼ƒ zolpidemã€triazolam å’Œ flunitrazepam å°åš´é‡ COPD æ‚£è€…çš„æ€¥æ€§æ•ˆæœ</li>
<li>é¡¯ç¤ºå„è—¥ç‰©å°å‘¼å¸åŠŸèƒ½çš„å½±éŸ¿å·®ç•°</li>

</ul>
<ol>
<li><strong>Kales A et al. (1979)</strong> - JAMA</li>
</ol>
<ul>
<li>é¦–æ¬¡æè¿°è‹¯äºŒæ°®å¹³é¡è—¥ç‰©çš„ã€Œåè·³æ€§å¤±çœ ã€ç¾è±¡</li>
<li>æŒ‡å‡º flunitrazepam å› ä¸­ç­‰åŠè¡°æœŸå¯èƒ½å¼•èµ·åœè—¥å¾Œåè·³æ€§å¤±çœ </li>

</ul>
<ol>
<li><strong>Rickels K (1986)</strong> - Acta Psychiatrica Scandinavica</li>
</ol>
<ul>
<li>ç¶œè¿°å®‰çœ è—¥çš„è‡¨åºŠä½¿ç”¨</li>
<li>è¨è«– flunitrazepam ä½œç‚ºé•·æ•ˆå®‰çœ è—¥çš„å®šä½</li>

</ul>
<ol>
<li><strong>Cook PJ (1986)</strong> - Acta Psychiatrica Scandinavica</li>
</ol>
<ul>
<li>æ¢è¨è€å¹´äººä½¿ç”¨è‹¯äºŒæ°®å¹³é¡å®‰çœ è—¥çš„è—¥æ•ˆå­¸è®ŠåŒ–</li>
<li>ç™¼ç¾è€å¹´äººå° flunitrazepam åæ‡‰å¢åŠ  2-3 å€</li>

</ul>
<p>é‡å°ç„¦æ…®é©æ‡‰ç—‡ï¼Œæª¢ç´¢åˆ° 15 ç¯‡ç›¸é—œæ–‡ç»ï¼Œå¤šæ•¸æ¶‰åŠè—¥ç‰©æ¿«ç”¨å’Œæ³•é†«æ¯’ç†å­¸è­°é¡Œã€‚</p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. migraine disorder</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.71%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. migraine with brainstem aura</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.63%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. anxiety</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.63%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ1 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02648776" target="_blank">NCT02648776</a></td><td>N/A</td><td>UNKNOWN</td><td>1400</td><td>Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9475831/" target="_blank">9475831</a></td><td>1998</td><td>Article</td><td>The Annals of pharma</td><td>Use and abuse of flunitrazepam.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6110431/" target="_blank">6110431</a></td><td>1981</td><td>Article</td><td>British journal of a</td><td>Flunitrazepam.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9169981/" target="_blank">9169981</a></td><td>1997</td><td>Article</td><td>Journal of clinical </td><td>Abuse liability of flunitrazepam.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/15365913/" target="_blank">15365913</a></td><td>2004</td><td>Article</td><td>Fortschritte der Neu</td><td>[Flunitrazepam and driving ability].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9107334/" target="_blank">9107334</a></td><td>1997</td><td>Article</td><td>Academic emergency m</td><td>Flunitrazepam and its involvement in date or acquaintance ra...</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 15 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. anxiety disorder</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.58%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ1 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02648776" target="_blank">NCT02648776</a></td><td>N/A</td><td>UNKNOWN</td><td>1400</td><td>Risk and Benefit Assessment of Hypnotic Agents for Sleep Disorders Among Elderly...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40704033/" target="_blank">40704033</a></td><td>2025</td><td>Article</td><td>Frontiers in psychia</td><td>Adverse events of pharmacological interventions for insomnia...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9475831/" target="_blank">9475831</a></td><td>1998</td><td>Article</td><td>The Annals of pharma</td><td>Use and abuse of flunitrazepam.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9169981/" target="_blank">9169981</a></td><td>1997</td><td>Article</td><td>Journal of clinical </td><td>Abuse liability of flunitrazepam.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11672967/" target="_blank">11672967</a></td><td>2001</td><td>Article</td><td>Forensic science int</td><td>Flunitrazepam: an evaluation of use, abuse and toxicity.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12063892/" target="_blank">12063892</a></td><td>2002</td><td>Article</td><td>American journal of </td><td>Club drugs: methylenedioxymethamphetamine, flunitrazepam, ke...</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 15 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. alcohol withdrawal delirium</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.50%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ6 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8214408/" target="_blank">8214408</a></td><td>1993</td><td>Article</td><td>Alcoholism, clinical</td><td>Intravenous flunitrazepam in the treatment of alcohol withdr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14557857/" target="_blank">14557857</a></td><td>2003</td><td>Article</td><td>Intensive care medic</td><td>Alcohol withdrawal severity is decreased by symptom-orientat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1329785/" target="_blank">1329785</a></td><td>1992</td><td>Article</td><td>Alcohol and alcoholi</td><td>Functional alterations in cerebral GABAA receptor complex as...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8383922/" target="_blank">8383922</a></td><td>1993</td><td>Article</td><td>Alcoholism, clinical</td><td>Chronic ethanol intoxication induces differential effects on...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/42267/" target="_blank">42267</a></td><td>1979</td><td>Article</td><td>Activitas nervosa su</td><td>Flunitrazepam in the treatment of delirium tremens. -- Preli...</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 1 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. migraine with or without aura, susceptibility to</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.49%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22938964/" target="_blank">22938964</a></td><td>2012</td><td>Article</td><td>Handbook of clinical</td><td>Animal models.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16201993/" target="_blank">16201993</a></td><td>2005</td><td>Article</td><td>Epilepsia</td><td>Rearranging receptors.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22266888/" target="_blank">22266888</a></td><td>2011</td><td>Article</td><td>Seminars in neurolog</td><td>Genetics of epilepsy.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34575901/" target="_blank">34575901</a></td><td>2021</td><td>Article</td><td>International journa</td><td>Selected Molecular Targets for Antiepileptogenesis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34209535/" target="_blank">34209535</a></td><td>2021</td><td>Article</td><td>International journa</td><td>Neuroinflammation: A Signature or a Cause of Epilepsy?</td></tr>
</tbody>
</table>
<p><em>...åŠå…¶ä»– 15 ç¯‡æ–‡ç»</em></p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. agoraphobia</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.39%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ2 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2836759/" target="_blank">2836759</a></td><td>1987</td><td>Article</td><td>Neuropsychobiology</td><td>A 3H-flunitrazepam binding inhibitor is present in psychiatr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2554193/" target="_blank">2554193</a></td><td>1989</td><td>Article</td><td>Neuropsychobiology</td><td>Further investigation on benzodiazepine binding inhibitory a...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. benign paroxysmal torticollis of infancy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.36%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. atrophoderma vermiculata</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.20%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

**ç®¡åˆ¶è—¥å“æ³¨æ„äº‹é …ï¼š**
æ°Ÿç¡è¥¿æ³®åœ¨å°ç£å±¬æ–¼ç¬¬ä¸‰ç´šç®¡åˆ¶è—¥å“ï¼Œä½¿ç”¨éœ€ç‰¹åˆ¥è¬¹æ…ã€‚

**åŸæ ¸å‡†é©æ‡‰ç—‡ï¼š**
- å¤±çœ 
- å®‰çœ ã€é®éœ
- å¤±çœ ç—‡
- å¯§ç¥è—¥

## å®‰å…¨æ€§è€ƒé‡

### é‡è¦è­¦èª

1. **æ¿«ç”¨æ½›åŠ›**ï¼šæ°Ÿç¡è¥¿æ³®å…·æœ‰é«˜åº¦æ¿«ç”¨æ½›åŠ›ï¼Œæ›¾è¢«åª’é«”å ±å°èˆ‡ã€Œç´„æœƒå¼·æš´è—¥ã€ç›¸é—œ
2. **é †è¡Œæ€§éºå¿˜**ï¼šå¯èƒ½å°è‡´æœè—¥å¾Œçš„è¨˜æ†¶ç©ºç™½
3. **å‘¼å¸æŠ‘åˆ¶**ï¼šèˆ‡é…’ç²¾æˆ–å…¶ä»–ä¸­æ¨ç¥ç¶“æŠ‘åˆ¶åŠ‘ä½µç”¨æ™‚é¢¨éšªå¢åŠ 
4. **ä¾è³´æ€§**ï¼šé•·æœŸä½¿ç”¨å¯èƒ½ç”¢ç”Ÿèº«é«”ä¾è³´

### ç‰¹æ®Šæ—ç¾¤æ³¨æ„äº‹é …

| æ—ç¾¤ | æ³¨æ„äº‹é … |
|------|----------|
| è€å¹´äºº | åæ‡‰å¢å¼·ï¼Œå»ºè­°æ¸›é‡ |
| COPD æ‚£è€… | å¯èƒ½åŠ é‡å‘¼å¸æŠ‘åˆ¶ |
| è‚åŠŸèƒ½ä¸å…¨ | ä»£è¬æ¸›æ…¢ï¼Œéœ€èª¿æ•´åŠ‘é‡ |
| å­•å©¦ | å¯èƒ½è‡´ç•¸ï¼Œæ‡·å­•æœŸé–“ç¦ç”¨ |

### è—¥ç‰©äº¤äº’ä½œç”¨

è‹¯äºŒæ°®å¹³é¡è—¥ç‰©çš„å¸¸è¦‹äº¤äº’ä½œç”¨ï¼š
- CYP3A4 æŠ‘åˆ¶åŠ‘å¯èƒ½å¢åŠ è¡€ä¸­æ¿ƒåº¦
- èˆ‡é…’ç²¾ã€é´‰ç‰‡é¡è—¥ç‰©ä½µç”¨å¢åŠ å‘¼å¸æŠ‘åˆ¶é¢¨éšª
- èˆ‡å…¶ä»– CNS æŠ‘åˆ¶åŠ‘æœ‰åŠ æˆæ•ˆæœ

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

**é…’ç²¾** ğŸ”´ Major
- å½±éŸ¿ï¼šé…’ç²¾é¡¯è‘—å¢å¼·é®éœä½œç”¨ï¼Œå¯èƒ½å°è‡´å‘¼å¸æŠ‘åˆ¶
- å»ºè­°ï¼šçµ•å°ç¦æ­¢é£²é…’

### è—¥ç‰©-è‰è—¥äº¤äº’ä½œç”¨ (DHI)

**å¡ç“¦** ğŸ”´ Major
- å½±éŸ¿ï¼šåš´é‡å¢å¼·ä¸­æ¨ç¥ç¶“æŠ‘åˆ¶
- å»ºè­°ï¼šç¦æ­¢ä½µç”¨

**çºˆè‰** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šå¢å¼·é®éœä½œç”¨
- å»ºè­°ï¼šé¿å…ä½µç”¨


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### é æ¸¬è©•ä¼°çµè«–

æ°Ÿç¡è¥¿æ³®çš„é æ¸¬é©æ‡‰ç—‡ä¸­ï¼Œã€Œå¤±çœ ã€å¯¦éš›ä¸Šæ˜¯åŸæ ¸å‡†é©æ‡‰ç—‡ï¼Œé©—è­‰äº† TxGNN æ¨¡å‹èƒ½æ­£ç¢ºè­˜åˆ¥å·²çŸ¥è—¥ç‰©-ç–¾ç—…é—œä¿‚ã€‚ã€Œç„¦æ…®ã€çš„é æ¸¬ä¹Ÿèˆ‡è‹¯äºŒæ°®å¹³é¡è—¥ç‰©çš„å·²çŸ¥è—¥ç†ä½œç”¨ä¸€è‡´ã€‚ã€Œåé ­ç—›ã€çš„é æ¸¬è¼ƒç‚ºæ–°ç©ï¼Œä½†ç¼ºä¹ç›´æ¥è­‰æ“šã€‚

### è­‰æ“šç­‰ç´šç¸½çµ

| é æ¸¬é©æ‡‰ç—‡ | TxGNN Score | è­‰æ“šç­‰ç´š | è©•ä¼° |
|------------|-------------|----------|------|
| å¤±çœ ï¼ˆç–¾ç—…ï¼‰ | 0.999 | L2 | å·²æ ¸å‡†é©æ‡‰ç—‡ï¼Œæœ‰å°ç£è‡¨åºŠè©¦é©— |
| åé ­ç—› | 0.997 | L5 | æ©Ÿè½‰å¯èƒ½ç›¸é—œï¼Œç¼ºä¹ç›´æ¥è­‰æ“š |
| ç„¦æ…® | 0.996 | L2 | è—¥ç†ä½œç”¨æ”¯æŒï¼Œæœ‰è‡¨åºŠè©¦é©— |

### å»ºè­°

1. **å¤±çœ **ï¼šæ­¤é æ¸¬ç¢ºèªå·²çŸ¥ç™‚æ•ˆï¼Œç„¡éœ€é¡å¤–ç ”ç©¶
2. **ç„¦æ…®**ï¼šé›–ç„¶æ©Ÿè½‰æ”¯æŒç™‚æ•ˆï¼Œä½†è€ƒé‡ç®¡åˆ¶è—¥å“èº«ä»½å’Œæ¿«ç”¨é¢¨éšªï¼Œä¸å»ºè­°å„ªå…ˆé–‹ç™¼æ­¤é©æ‡‰ç—‡
3. **åé ­ç—›**ï¼šç¼ºä¹ç›´æ¥è­‰æ“šï¼Œä¸”æœ‰æ›´å®‰å…¨çš„æ›¿ä»£è—¥ç‰©

### æ•´é«”è©•ä¼°

ç”±æ–¼æ°Ÿç¡è¥¿æ³®çš„ç®¡åˆ¶è—¥å“åœ°ä½å’Œæ¿«ç”¨é¢¨éšªï¼Œä¸å»ºè­°å°‡å…¶ä½œç‚ºè€è—¥æ–°ç”¨çš„å„ªå…ˆå€™é¸è—¥ç‰©ã€‚é æ¸¬çš„ã€Œæ–°ã€é©æ‡‰ç—‡å¯¦éš›ä¸Šå¤šç‚ºå·²çŸ¥æˆ–å¯é æœŸçš„è—¥ç†ä½œç”¨å»¶ä¼¸ã€‚

---

*å ±å‘Šç”Ÿæˆæ—¥æœŸï¼š2026-02-11*
*è³‡æ–™ä¾†æºï¼šTxGNN çŸ¥è­˜åœ–è­œé æ¸¬ã€ClinicalTrials.govã€PubMedã€å°ç£ FDA*


---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Naproxen]({{ "/drugs/naproxen/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Salicylic Acid]({{ "/drugs/salicylic_acid/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Alprostadil]({{ "/drugs/alprostadil/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cerliponase Alfa]({{ "/drugs/cerliponase_alfa/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Simoctocog Alfa]({{ "/drugs/simoctocog_alfa/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Flunitrazepamè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/flunitrazepam/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_flunitrazepam,
  title = {Flunitrazepamè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/flunitrazepam/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
